Login Register Cart 0
Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Clinical Trial

The Effects of Melatonin on the Oxidative Stress and Duration of Atrial Fibrillation after Coronary Artery Bypass Graft Surgery: A Randomized Controlled Trial

Author(s): Saghar Barati, Alireza Jahangirifard, Zargham H. Ahmadi, Maria Tavakoli-Ardakani and Farzaneh Dastan*

Volume 21, Issue 6, 2021

Published on: 28 July, 2020

Page: [1142 - 1149] Pages: 8

DOI: 10.2174/1871530320666200728152307

Price: $65

Abstract

Background: Atrial Fibrillation (AF) is a common complication following Coronary artery bypass graft (CABG) Surgery, which may be due to oxidative stress, necrosis and inflammation during CABG and can lead to increases the length of hospital stay and the risk of morbidity and mortality. Melatonin is a hormone with anti-oxidant and anti-inflammatory properties in the cardiovascular system. This study assessed the efficacy of sublingual consumption of melatonin in reducing necrosis and inflammation, in patients undergoing CABG with respect to C-reactive protein (hs-CRP), Creatine Kinase-Muscle-Brain subunits (CK-MB) and cardiac Troponin T (cTnT) levels.

Methods: One hundred and two patients were enrolled and twenty-six patients were excluded during the study process and finally seventy-six patients undergoing CABG surgery randomly assigned to melatonin group (n = 38, 12 mg sublingual melatonin the evening before and 1 hour before surgery, or the control group which did not receive Melatonin, n = 38). Three patients in the melatonin group and three patients in the control group were excluded from the study because of discontinued intervention and lost to follow up. The samples were collected before and 24 hours after surgery. hs-CRP, CK-MB, and cTnT levels were measured in all patients with the Elisa method.

Results: There was no significant difference in influencing variables among the groups at the baseline. The incidence of AF following CABG surgery was not statistically significant between the two groups, (p-value = 0.71). However, the duration of AF (p-value = 0.01), the levels of hs-CRP (p-value = 0.001) and CK-MB (p-value = 0.004) measured, 24 hours after surgery were significantly lower in the melatonin group. cTnT levels measured 24 hours post-CABG did not show any significant difference in both groups (p-value = 0.52).

Conclusion: Our findings suggest that the administration of melatonin may help modulate oxidative stress, based on the reduction of the levels of hs-CRP, CK-MB, and the duration of AF following CABG surgery.

Keywords: Atrial fibrillation, coronary artery, bypass graft surgery, melatonin, oxidative stress, angina.

« Previous Next »
Graphical Abstract

[1]
Nashef, S. Bosco, P.In Core Topics in Cardiothorasic Critical Care; Valchanov, K.; Jones, N.; Hogue, C.W., Eds.; Cambridge University Press: Cambridge, 2018, pp. 313-316.
[http://dx.doi.org/10.1017/9781316443415.040]
[2]
Benedetto, U.; Puskas, J.; Kappetein, A.P.; Brown, W.M., III; Horkay, F.; Boonstra, P.W.; Bogáts, G.; Noiseux, N.; Dressler, O.; Angelini, G.D.; Stone, G.W.; Serruys, P.W.; Sabik, J.F.; Taggart, D.P. Off-Pump versus on-pump bypass surgery for left main coronary artery disease. J. Am. Coll. Cardiol., 2019, 74(6), 729-740.
[http://dx.doi.org/10.1016/j.jacc.2019.05.063] [PMID: 31395122]
[3]
Liakopoulos, O.J.; Schlachtenberger, G.; Wendt, D.; Choi, Y.H.; Slottosch, I.; Welp, H.; Schiller, W.; Martens, S.; Welz, A.; Neuhäuser, M.; Jakob, H.; Wahlers, T.; Thielmann, M. Early Clinical Outcomes of Surgical Myocardial Revascularization for Acute Coronary Syndromes Complicated by Cardiogenic Shock: A report from the north-rhine-westphalia surgical myocardial infarction registry. J. Am. Heart Assoc., 2019, 8(10), e012049.
[http://dx.doi.org/10.1161/JAHA.119.012049] [PMID: 31070076]
[4]
Arif, M.A.; Ahmeid, M.S.; Allaw, S.A. Malondialdehyde level in the patients subjected to open heart surgery in association with lipid profile. Mustansiriya Med. J., 2019, 18(1), 30-35.
[http://dx.doi.org/10.4103/MJ.MJ_34_18 ]
[5]
Batra, G.; Ahlsson, A.; Lindahl, B.; Lindhagen, L.; Wickbom, A.; Oldgren, J. Atrial fibrillation in patients undergoing coronary artery surgery is associated with adverse outcome. Ups. J. Med. Sci., 2019, 124(1), 70-77.
[http://dx.doi.org/10.1080/03009734.2018.1504148] [PMID: 30265179]
[6]
Filardo, G.; Damiano, R.J., Jr; Ailawadi, G.; Thourani, V.H.; Pollock, B.D.; Sass, D.M.; Phan, T.K.; Nguyen, H.; da Graca, B. Epidemiology of new-onset atrial fibrillation following coronary artery bypass graft surgery. Heart, 2018, 104(12), 985-992.
[http://dx.doi.org/10.1136/heartjnl-2017-312150] [PMID: 29326112]
[7]
Scott, L., Jr; Li, N.; Dobrev, D. Role of inflammatory signaling in atrial fibrillation. Int. J. Cardiol., 2019, 287, 195-200.
[http://dx.doi.org/10.1016/j.ijcard.2018.10.020] [PMID: 30316645]
[8]
Aydin, S.; Ugur, K.; Aydin, S.; Sahin, İ.; Yardim, M. Biomarkers in acute myocardial infarction: Current perspectives. Vasc. Health Risk Manag., 2019, 15, 1-10.
[http://dx.doi.org/10.2147/VHRM.S166157] [PMID: 30697054]
[9]
Chakrabarty, T.; Tirupathi, S.; Thompson, A. How to use: Creatine kinase. Arch. Dis. Child. Educ. Pract. Ed., 2019, 105(3), 157-163.
[http://dx.doi.org/10.1136/archdischild-2019-317184]
[10]
Ulugol, H.; Aksu, U.; Kocyigit, M.; Kilercik, M.; Karduz, G.; Okten, M.; Toraman, F. Comparative Effects of Blood and Crystalloid Cardioplegia on Cellular Injury and Oxidative Stress in Cardiovascular Surgery. Ann. Thorac. Cardiovasc. Surg., 2019, 25(1), 10-17.
[http://dx.doi.org/10.5761/atcs.oa.18-00113] [PMID: 30158392]
[11]
Aarabi, G.; Schnabel, R.B.; Heydecke, G.; Seedorf, U. Potential impact of oral inflammations on cardiac functions and atrial fibrillation. Biomolecules, 2018, 8(3), 66.
[http://dx.doi.org/10.3390/biom8030066] [PMID: 30071583]
[12]
Slominski, A.T.; Hardeland, R.; Zmijewski, M.A.; Slominski, R.M.; Reiter, R.J.; Paus, R. Melatonin: A cutaneous perspective on its production, metabolism, and functions. J. Invest. Dermatol., 2018, 138(3), 490-499.
[http://dx.doi.org/10.1016/j.jid.2017.10.025] [PMID: 29428440]
[13]
Burchakov, D.I.; Uspenskaya, Y.B. Antioxidant, anti-inflammatory and sedative effects of melatonin: results of clinical trials. Zh Nevrol Psikhiatr Im S S Korsakova, 2017, 117(4. Vyp. 2), 67-73.
[http://dx.doi.org/10.17116/jnevro20171174267-73] [PMID: 28777367]
[14]
Jiki, Z.; Lecour, S.; Nduhirabandi, F. Cardiovascular benefits of dietary melatonin: A myth or a reality? Front. Physiol., 2018, 9, 528.
[http://dx.doi.org/10.3389/fphys.2018.00528] [PMID: 29867569]
[15]
Baker, J.; Kimpinski, K. Role of melatonin in blood pressure regulation: An adjunct anti-hypertensive agent. Clin. Exp. Pharmacol. Physiol., 2018, 45(8), 755-766.
[http://dx.doi.org/10.1111/1440-1681.12942] [PMID: 29603319]
[16]
Favero, G.; Franceschetti, L.; Buffoli, B.; Moghadasian, M.H.; Reiter, R.J.; Rodella, L.F.; Rezzani, R. Melatonin: Protection against age-related cardiac pathology. Ageing Res. Rev., 2017, 35, 336-349.
[http://dx.doi.org/10.1016/j.arr.2016.11.007] [PMID: 27884595]
[17]
Nduhirabandi, F.; Maarman, G.J. Melatonin in heart failure: A Promising therapeutic strategy? Molecules, 2018, 23(7), E1819.
[http://dx.doi.org/10.3390/molecules23071819] [PMID: 30037127]
[18]
Ghaeli, P.; Vejdani, S.; Ariamanesh, A.; Hajhossein Talasaz, A. Effect of melatonin on cardiac injury after primary percutaneous coronary intervention: A randomized controlled trial. Iran. J. Pharm. Res., 2015, 14(3), 851-855.
[PMID: 26330873]
[19]
Dwaich, K.H.; Al-Amran, F.G.; Al-Sheibani, B.I.; Al-Aubaidy, H.A. Melatonin effects on myocardial ischemia-reperfusion injury: Impact on the outcome in patients undergoing coronary artery bypass grafting surgery. Int. J. Cardiol., 2016, 221, 977-986.
[http://dx.doi.org/10.1016/j.ijcard.2016.07.108] [PMID: 27441478]
[20]
Shafiei, E.; Bahtoei, M.; Raj, P.; Ostovar, A.; Iranpour, D.; Akbarzadeh, S.; Shahryari, H.; Anvaripour, A.; Tahmasebi, R.; Netticadan, T.; Movahed, A. Effects of N-acetyl cysteine and melatonin on early reperfusion injury in patients undergoing coronary artery bypass grafting: A randomized, open-labeled, placebo-controlled trial. Medicine, 2018, 97(30), e11383.
[http://dx.doi.org/10.1097/md.0000000000011383] [PMID: 30045259]
[21]
Farouk Musa, A.; Quan, C.Z.; Xin, L.Z.; Soni, T.; Dillon, J.; Hay, Y.K.; Nordin, R.B. A retrospective study on atrial fibrillation after coronary artery bypass grafting surgery at The National Heart Institute, Kuala Lumpur. F1000 Res., 2018, 7, 164.
[http://dx.doi.org/10.12688/f1000research.13244.1] [PMID: 30254739]
[22]
Dave, S.; Nirgude, A.; Gujjar, P.; Sharma, R. Incidence and risk factors for development of atrial fibrillation after cardiac surgery under cardiopulmonary bypass. Indian J. Anaesth., 2018, 62(11), 887-891.
[http://dx.doi.org/10.4103/ija.IJA_6_18] [PMID: 30532326]
[23]
Zhu, L.; Zou, Y.; Wang, Y.; Luo, X.; Sun, K.; Wang, H.; Jia, L.; Liu, Y.; Zou, J.; Yuan, Z.; Hui, R.; Kang, L.; Song, L.; Wang, J. Prognostic significance of plasma high-sensitivity c-reactive protein in patients with hypertrophic cardiomyopathy. J. Am. Heart Assoc., 2017, 6(2), e004529.
[http://dx.doi.org/10.1161/JAHA.116.004529] [PMID: 28154166]
[24]
Dwaich, K.H.; Al-Amran, F.G.; Al-Sheibani, B.I.; Yousif, N.G.; Hadi, N.R. The cardioprotective role of melatonin against myocardial injury in patients undergoing coronary artery bypass grafting surgery. Vasc. Invest. Ther., 2018, 1(2), 41-49.
[http://dx.doi.org/10.4103/VIT.VIT_12_18 ]
[25]
Baltatu, O.C.; Senar, S.; Campos, L.A.; Cipolla-Neto, J. Cardioprotective Melatonin: Translating from Proof-of-Concept Studies to Therapeutic Use. Int. J. Mol. Sci., 2019, 20(18), 4342.
[http://dx.doi.org/10.3390/ijms20184342] [PMID: 31491852]
[26]
Mahmood, D. Pleiotropic effects of Melatonin. Drug Res. (Stuttg.), 2019, 69(2), 65-74.
[http://dx.doi.org/10.1055/a-0656-6643] [PMID: 30060265]
[27]
Guo, X.Y.; Luo, A.L.; Ren, H.Z.; Yie, T.H.; Huang, Y.G. Perioperative melatonin secretion rhyme in patients undergoing coronary artery bypass grafting surgery. Zhongguo yi xue ke xue yuan xue bao, 2003, 25(5), 594-598.
[PMID: 14650166]
[28]
Farzaei, M.H.; Hajialyani, M.; Naseri, R. Nonvitamin and Nonmineral Nutritional Supplements. Elsevier, 2019, 99-105.
[29]
Haghjooy Javanmard, S.; Ziaei, A.; Ziaei, S.; Ziaei, E.; Mirmohammad-Sadeghi, M. The effect of preoperative melatonin on nuclear erythroid 2-related factor 2 activation in patients undergoing coronary artery bypass grafting surgery. Oxid. Med. Cell. Longev., 2013, 2013, 676829.
[http://dx.doi.org/10.1155/2013/676829] [PMID: 23691266]

Rights & Permissions Print Cite
Article Metrics
24
1
© 2024 Bentham Science Publishers | Privacy Policy